Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenelinkGNLKQ Gross Margin % is 24.75% as of Sep. 2013.
Gross Margin % is calculated as gross profit divided by its revenue. Genelink's Gross Profit for the
three
months ended in Sep. 2013 was $0.07 Mil. Genelink's Revenue for the
three
months ended in Sep. 2013 was $0.30 Mil. Therefore, Genelink's Gross Margin % for the quarter that ended in Sep. 2013 was 24.75%.
The historical rank and industry rank for Genelink's Gross Margin % or its related term are showing as below:
GNLKQ's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.91 * Ranked among companies with meaningful Gross Margin % only.
Genelink had a gross margin of 24.75% for the quarter that ended in Sep. 2013 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Genelink was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Genelink had a gross margin of 24.75% for the quarter that ended in Sep. 2013 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Genelink Gross Margin % Related Terms
Genelink Gross Margin % Historical Data
* Premium members only.
The historical data trend for Genelink's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNLKQ vs VITIF, HSTC, NTRR: Gross Margin % Comparison
For the Biotechnology subindustry, Genelink's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genelink Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genelink's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Genelink's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Genelink (GNLKQ) has a Gross Margin % of 24.75% as of Sep. 2013. Gross margin is the ratio of total gross profit to net sales. View historical data on Genelink and its competitors.
Is Genelink's Gross Margin % too high?
Genelink's current Gross Margin % is 24.75%. The Biotechnology industry median Gross Margin % is 60.91. Genelink's value of 24.75% is 59.4% below this industry median.
How does Genelink's Gross Margin % compare to VITIF and HSTC?
Genelink's Gross Margin % of 24.75% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.91. Genelink's value of 24.75% is 59.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genelink's current Gross Margin % of 24.75% is 59.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Genelink and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genelink's current Gross Margin % is 24.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genelink stock overvalued right now?
Genelink (GNLKQ) has a current Gross Margin % of 24.75%. The current Gross Margin % is 24.75% and 59.4% below the Biotechnology industry median of 60.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Genelink (GNLKQ), the current Gross Margin % is 24.75% as of Sep. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies. These small differences in DNA, called SNPs can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. The company's scientists use the DNA assessments information from each client to formulate products to optimize health and wellness within normal ranges. The company has a compilation of issued and pending patents that center on using DNA analysis for the purpose of customizing nutrition and skin care formulations for wellness and anti-aging.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNLKQ has been successfully added to your 
